Cold chain News and Research

RSS

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.

24 Jul 2020

Nanotechnology plays major role in COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

15 Jul 2020

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

13 Jul 2020

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

From EKF Diagnostics 13 Jul 2020

Scientists find way to prevent warmed-up vaccines from degrading

Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated.

8 Jun 2020

At-home finger prick COVID-19 antibody testing

The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.

2 Jun 2020

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.

From EKF Diagnostics 26 May 2020

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science.

12 May 2020

RNAssist and Rapid Labs agree on a manufacturing and supply agreement for genoPHIX and vivoPHIX

RNAssist has developed several universal biological sample stabilization, fixation and microbial inactivation reagents.

From Rapid Labs Ltd 23 Jan 2020

Climate change and children’s health

UNICEF says that climate change is posing an immense challenge to the health of children worldwide. Though children commonly have the least to do with the actions and attitudes that lead to climate change, they are the ones who will have to bear the brunt of it.

2 Dec 2019

WHO begins emergency vaccination campaign to slow measles outbreak in DR Congo

The WHO and government of the DR Congo have begun an emergency vaccination program to stop the spread of measles in the country.

27 Sep 2019

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Key barriers that prevent access to antibiotics in low- and middle-income countries

Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics.

9 Apr 2019

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

A DNA-encoded monoclonal antibody prevents Zika infection in mice and non-human primates, researchers report April 5 in the journal Molecular Therapy.

8 Apr 2019

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

23 Jan 2019

MOF vaccines could increase access to immunization and reduce the risk of global pandemics

Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.

23 Jul 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

Congo to start vaccinating populations against Ebola today to combat outbreak

Congo is facing a new Ebola outbreak and the health officials have announced that starting today, (Monday 21st May 2018), response teams would begin administering an experimental Ebola vaccine in Mbandaka.

21 May 2018

Envirotainer voted as Best Active Temperature-Controlled Packaging Solution Provider

Envirotainer, the global market leader in secure cold chain solutions for the pharmaceutical supply chain, today was voted the Best Active Temperature-Controlled Packaging Solution Provider at the Asia-Pacific Bioprocessing Excellence Award 2018.

2 Feb 2018

Timestrip provides smart indicators to help fight rabies in Africa

Timestrip – the UK-based developer of ‘smart indicator’ technology – has provided self-adhesive temperature monitoring strips to Malawi to ensure that canine rabies vaccines are maintained in their ‘Goldilocks zone’ – neither too hot nor too cold. The easy to use indicators can be deployed as a low cost alternative to thermometers in both storage fridges and field cooler boxes.

24 Jan 2018